News
Study evaluates novel small molecule TNF-alpha inhibitor as potential alternative to biologic treatments TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback